Organogenesis Holdings (ORGO) EPS (Weighted Average and Diluted) (2018 - 2026)
Organogenesis Holdings (ORGO) recorded quarterly EPS (Weighted Average and Diluted) of -$0.44 in Q1 2026, down 262.96% quarter-over-quarter from $0.27 in Q4 2025, and down 158.82% on a YoY basis from $0.75 in Q1 2025.
Organogenesis Holdings (ORGO) EPS (Weighted Average and Diluted) (2018 - 2026) Analysis & Trends
Organogenesis Holdings' EPS (Weighted Average and Diluted) history runs 9 years deep, the most recent figure standing at -$0.44 for Q1 2026.
- In Q1 2026, EPS (Weighted Average and Diluted) fell 158.82% year-over-year to -$0.44; the TTM figure through Mar 2026 stood at -$0.16 (up 5.88% YoY), while the FY2025 annual figure was $0.15, up 1600.0% from the prior year.
- EPS (Weighted Average and Diluted) was -$0.44 for Q1 2026 at Organogenesis Holdings, down from $0.27 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.27 in Q4 2025 to a low of -$0.44 in Q1 2026.
- Historically, EPS (Weighted Average and Diluted) has averaged -$0.01 across 5 years, with a median of $0.0 in 2022.
- The sharpest annual moves came in 2023 and 2025: EPS (Weighted Average and Diluted) surged 1133.07% in 2023, then plunged 750.0% in 2025.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.06 in 2022, then sank by 107.13% to -$0.0 in 2023, then jumped by 1034.84% to $0.04 in 2024, then surged by 575.0% to $0.27 in 2025, then sank by 262.96% to -$0.44 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.44 (Q1 2026), $0.27 (Q4 2025), and $0.11 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 0.31 |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 1.42 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 5.82 |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 1.91 |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | -2.39 |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | 0.11 |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | -0.40 |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 1.80 |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 0.52 |
| 10 | Organogenesis Holdings | 300.96 Mn | 208.86 Mn | 11.46 Mn | -0.44 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.44 |
| Dec 31, 2025 | 0.27 |
| Sep 30, 2025 | 0.11 |
| Jun 30, 2025 | -0.10 |
| Mar 31, 2025 | -0.17 |
| Dec 31, 2024 | 0.04 |
| Sep 30, 2024 | 0.09 |
| Jun 30, 2024 | -0.13 |
| Mar 31, 2024 | -0.02 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.02 |
| Jun 30, 2023 | 0.04 |
| Mar 31, 2023 | -0.02 |
| Dec 31, 2022 | 0.06 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | 0.07 |
| Mar 31, 2022 | -0.01 |
| Dec 31, 2021 | 0.38 |
| Sep 30, 2021 | 0.09 |
| Jun 30, 2021 | 0.15 |